The ECL-dot blot assay is highly sensitive, detecting as little as 0.01 pmol/L STK1p, which is approximately 120 times more sensitive (18, 35) than a TK1 enzyme-linked immunosorbent assay (36), which can detect invisible malignant tumors (35). Here, TK1 is linked to cancer.